A novel treatment for fibromyalgia improves clinical outcomes in a community-based study.

Objectives: Immunoreactant load was assessed by using lymphocyte response assay [LRA] with cell response/blastogenic mixed cell culture to determine if substitution of reactive items would be associated with remission of symptoms in subjects with fibromyalgia syndrome [FMS]. Methods: Fibromyalgia su...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Musculoskeletal Pain Vol. 6; no. 2; pp. 133 - 150
Autores principales: Deuster PA, Jaffe RM
Formato: research tables/charts Journal Article
Publicado: Taylor & Francis Ltd 1998
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107181784&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 107181784
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10582452
        88S
      jtl: Journal of Musculoskeletal Pain
      issn: 10582452
      maglogo: N
    pubinfo:
      dt: 1998
      vid: 6
      iid: 2
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        107181784
        107181784
        1999027272
        107181784
      ppf: 133
      ppct: 17
      formats:
      tig:
        atl: A novel treatment for fibromyalgia improves clinical outcomes in a community-based study.
      aug:
        au:
          Deuster PA
          Jaffe RM
        affil: Health Studies Collegium, 1890 Preston White Drive, Reston, VA 22091
      sug:
        subj:
          Fibromyalgia Immunology
          Fibromyalgia Therapy
          Hypersensitivity Prevention and Control
          Life Style
          Fibromyalgia Symptoms
          Funding Source
          Prospective Studies
          Quasi-Experimental Studies
          Treatment Outcomes
          Immunoassay
          Tissue Culture Techniques
          Antigens Diagnostic Use
          Antigen-Antibody Reactions Evaluation
          Questionnaires
          Self Report
          Pain Measurement
          Support Groups
          Fibromyalgia Diet Therapy
          Dietary Supplementation
          Environmental Exposure Prevention and Control
          Patient Compliance
          Descriptive Statistics
          Repeated Measures
          Analysis of Variance
          Data Analysis Software
          P-Value
          Sex Factors
          Age Factors
          Adult
          Middle Age
          Female
          Male
          Human
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Objectives: Immunoreactant load was assessed by using lymphocyte response assay [LRA] with cell response/blastogenic mixed cell culture to determine if substitution of reactive items would be associated with remission of symptoms in subjects with fibromyalgia syndrome [FMS]. Methods: Fibromyalgia subjects [N 51] were assigned to a control [C: N = I I] or treatment [T: N 40] group; C maintained usual life-styles and T, after LRA testing, underwent a program of substitution and nutritional repletion with metabolic intermediates. All subjects participated in biweekly support groups and completed questionnaires [0 months, three months, and six months] to document changes. Results: After six months T experienced 50% less pain, 70% less depression, 50% more energy, and 30% less stiffness, whereas C reported an increase in pain and depression, and comparable levels of stiffness and energy as compared to pre-program levels. Conclusions: These data suggest that reducing the inununoreactant load in FMS, while stimulating repair, may help re-establish homeostasis and neuroimmune hormonal control.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N